Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation Because of Hepatocellular Carcinoma
Transplantation Proceedings · 2023
DOI: 10.1016/j.transproceed.2023.01.038 ↗Kurz gefasst
Fachartikel in der Zeitschrift Transplantation Proceedings, 2023. Verfasst von Sami Akbulut und 9 weiteren Autor:innen. Beteiligte Einrichtung: Department of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey. Electronic address: akbulutsami@gmail.co…. Hauptthemen laut MEDLINE: COVID-19, Carcinoma, Hepatocellular, Liver Transplantation, Liver Neoplasms. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 25 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
BACKGROUND AND AIM: Many clinical studies have shown that the COVID-19 case fatality rate is higher in older patients, those with comorbidities, those with immunosuppressive conditions, and those who stay in the intensive care unit. This study aims to evaluate the clinical outcomes of 66 liver transplant (LT) patients with primary liver cancer who were exposed to COVID-19 infection. METHODS: Demographic and clinical data of 66 patients with primary liver cancer (hepatocellular carcinoma = 64, hepatoblastoma = 1, cholangiocarcinoma = 1) who underwent LT in our institute and were exposed to COVID-19 infection between March 2020 and November 2021 were analyzed in this cross-sectional study. The following data of the patients were recorded: age, sex, body mass index (kg/m2), blood group, underlying primary liver disease, smoking, tumor characteristics, post-transplant immunosuppressive agents, COVID-19 symptoms, hospitalization, intensive care unit stay, intubation, and other clinical features. RESULTS: There were 55 (83.3%) male and 11 (16.7%) female patients, with a median age of 58 years. Sixty-four patients were exposed to COVID-19 only once, whereas the remaining 2 patients were exposed 2 and 4 times, respectively. After exposure to COVID-19, it was determined that 37 patients used antiviral drugs, 25 were hospitalized, 9 were followed in the intensive care unit, and 3 were intubated. One intubated patient was under hospital follow-up because of biliary complications before exposure to COVID-19, and this patient died from sepsis. CONCLUSION: The low mortality rate of LT patients with primary liver cancer exposed to COVID-19 infection can be attributed to background immunosuppression that prevents cytokine storm. However, it is appropriate to support this study with multicenter studies to make strong comments on this issue.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey. Electronic address: akbulutsami@gmail.com.
- Department of Surgical Nursing, Inonu University Faculty of Nursing, Malatya, Turkey.
- Department of Surgery, Aminu Kano Teaching Hospital, Kano, Nigeria.
- Department of Nursing Service, Inonu University Faculty of Medicine, Malatya, Turkey.
- Department of Surgery and Liver Transplant Institute, Inonu University Faculty of Medicine, Malatya, Turkey.
- King Hussein Medical Center, Royal Medical Services, Amman, Jordan.
Zitieren
APA
Akbulut, S., Bagci, N., Akyuz, M., Garzali, I. U., Saritas, H., Tamer, M., Ince, V., Unsal, S., Aloun, A., & Yilmaz, S. (2023). Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation Because of Hepatocellular Carcinoma. Transplantation Proceedings. https://doi.org/10.1016/j.transproceed.2023.01.038
Vancouver
Akbulut S, Bagci N, Akyuz M, Garzali IU, Saritas H, Tamer M, et al. Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation Because of Hepatocellular Carcinoma. Transplantation Proceedings. 2023. doi:10.1016/j.transproceed.2023.01.038
BibTeX
@article{Akbulut2023,
author = {Akbulut, Sami and Bagci, Nazlican and Akyuz, Musap and Garzali, Ibrahim Umar and Saritas, Hasan and Tamer, Murat and Ince, Volkan and Unsal, Selver and Aloun, Ali and Yilmaz, Sezai},
title = {Effect of COVID-19 Pandemic on Patients Who Have Undergone Liver Transplantation Because of Hepatocellular Carcinoma},
journal = {Transplantation Proceedings},
year = {2023},
doi = {10.1016/j.transproceed.2023.01.038}
}
EUVIMED